Back to search
H.Pylori Gastrointestinal Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which H.Pylori Gastrointestinal Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which H.Pylori Gastrointestinal Disease trials you may qualify forThis study, titled CURE-H. Pylori, is a three-arm, parallel-group, open-label, randomized controlled trial designed to evaluate the effectiveness of Dexlansopra…
Helicobacter pylori (H pylori) is the main cause of chronic gastritis and peptic ulcer disease. In addition, is the main risk factor for gastric adenocarcinoma…
To assess antimicrobial resistance rates and minimal inhibitory concentrations in H. pylori isolated from patients with upper gastrointestinal disease with long…
The study is aimed to determine the potential of volatile marker testing for gastric cancer screening. The study will be addressing the role of confounding fac…
The goal of this clinical trial is to assess the differential expression of miR-155 and miRNA-204 in relation to gastritis, and assess their relation with the p…
Background: Helicobacter pylori is a major risk factor for gastric cancer, yet in many developing countries, including Bhutan where gastric cancer incidence is…